China SXT Pharmaceuticals, Inc. (SXTC) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

China SXT Pharmaceuticals, Inc. (SXTC) closed at USD 0.07 on 2026-10-15, a change of -100 % over the past year, with a market capitalization of USD 673,237.

China SXT Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

China SXT Pharmaceuticals, Inc. key figures

Previous close

USD 0.07 (2026-10-15)

1-year change

-100 %

Market cap

USD 673,237

Enterprise value

USD -27.17M

P/E ratio (trailing)

-0.00

P/E ratio (forward)

n/a

EPS (trailing)

-730.40

EPS (forward)

n/a

PEG ratio

n/a

Price to book

0.00

Revenue growth

-43.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.08

Employees

56

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, including Directly-Oral-TCMP, and After-Soaking-Oral TCMP; Fine TCMP and Regular TCMP products; and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for China SXT Pharmaceuticals, Inc. and compare it with other stocks.